Rs17817449 Variant Increases the Risk of Severe Obesity in a Brazilian Cohort: A Case-Control Study

Purpose: Obesity is a complex disease caused by a combination of genetic, environmental, and epigenetic factors, and is associated with an increased risk of chronic diseases. The leptin-melanocortin pathway integrates peripheral signals about the body's energy stores with a central neuronal circuit in the hypothalamus. This pathway has been extensively studied over the years, as genetic variations in genes related to it may play a crucial role in determining an individual's susceptibility to obesity. Therefore, we analyzed the association between obesity and specific polymorphisms in leptin-melanocortin-related genes such as rs1137101, rs1042571, rs7799039, rs6265, rs17817449, rs121909065, and rs16147/rs5574.

Patients And Methods: The study enrolled 501 participants from Rio de Janeiro, Brazil, with obesity class II or greater (BMI ≥ 35 kg/m2) and normal weight controls (18.5≤ BMI ≤24.9 kg/m2). We collected demographic, body composition, biochemical, and genotyping data by real-time PCR, and performed logistic and linear regression analyses to investigate the association of polymorphisms with severe obesity status and obesity-related quantitative parameters.

Results: Individuals with severe obesity had significantly higher anthropometric measures, blood pressure, and biochemical levels. The rs17817449 TT genotype was associated with a significantly higher risk of developing severe obesity, and distinct cytokine expression was observed across the rs17817449 genotypes. The rs6265 dominant-model and rs16147 CC genotypes were associated with triglyceride levels and childhood obesity, respectively. Finally, individuals with obesity were more likely to carry a greater number of risk alleles than those without obesity.

Conclusion: Our study observed an important association between rs17817449 polymorphism with obesity and obesity-related traits. Additionally, rs6265 dominant-model was associated with triglyceride serum levels, and rs16147 may have a role in obesity onset.

References

Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart A . Leptin and Obesity: Role and Clinical Implication. Front Endocrinol (Lausanne). 2021; 12:585887. PMC: 8167040. DOI: 10.3389/fendo.2021.585887. View

Katus U, Villa I, Ringmets I, Veidebaum T, Harro J . Neuropeptide Y gene variants in obesity, dietary intake, blood pressure, lipid and glucose metabolism: A longitudinal birth cohort study. Peptides. 2021; 139:170524. DOI: 10.1016/j.peptides.2021.170524. View

Tan S, Scherag A, Janssen O, Hahn S, Lahner H, Dietz T . Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). BMC Med Genet. 2010; 11:12. PMC: 2824654. DOI: 10.1186/1471-2350-11-12. View

Cone . The Central Melanocortin System and Energy Homeostasis. Trends Endocrinol Metab. 1999; 10(6):211-216. DOI: 10.1016/s1043-2760(99)00153-8. View

Loos R, Yeo G . The genetics of obesity: from discovery to biology. Nat Rev Genet. 2021; 23(2):120-133. PMC: 8459824. DOI: 10.1038/s41576-021-00414-z. View

Lan N, Lu Y, Zhang Y, Pu S, Xi H, Nie X . FTO - A Common Genetic Basis for Obesity and Cancer. Front Genet. 2020; 11:559138. PMC: 7701174. DOI: 10.3389/fgene.2020.559138. View

Zhao X, Gang X, He G, Li Z, Lv Y, Han Q . Obesity Increases the Severity and Mortality of Influenza and COVID-19: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021; 11:595109. PMC: 7779975. DOI: 10.3389/fendo.2020.595109. View

Kitahara C, Flint A, Berrington de Gonzalez A, Bernstein L, Brotzman M, MacInnis R . Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med. 2014; 11(7):e1001673. PMC: 4087039. DOI: 10.1371/journal.pmed.1001673. View

Proenca da Fonseca A, Mastronardi C, Johar A, Arcos-Burgos M, Paz-Filho G . Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies. J Diabetes Complications. 2017; 31(10):1549-1561. DOI: 10.1016/j.jdiacomp.2017.04.026. View

10.

Harno E, Gali Ramamoorthy T, Coll A, White A . POMC: The Physiological Power of Hormone Processing. Physiol Rev. 2018; 98(4):2381-2430. PMC: 6170974. DOI: 10.1152/physrev.00024.2017. View

11.

Proenca da Fonseca A, Abreu G, Zembrzuski V, Junior M, Carneiro J, Nogueira Neto J . Study of LEP, MRAP2 and POMC genes as potential causes of severe obesity in Brazilian patients. Eat Weight Disord. 2020; 26(5):1399-1408. DOI: 10.1007/s40519-020-00946-z. View

12.

Kowalska I, Malecki M, Straczkowski M, Skupien J, Karczewska-Kupczewska M, Nikolajuk A . The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes. Diabetes Metab. 2009; 35(4):328-31. DOI: 10.1016/j.diabet.2009.03.004. View

13.

Srivastava A, Mittal B, Prakash J, Srivastava P, Srivastava N . Analysis of MC4R rs17782313, POMC rs1042571, APOE-Hha1 and AGRP rs3412352 genetic variants with susceptibility to obesity risk in North Indians. Ann Hum Biol. 2015; 43(3):285-8. DOI: 10.3109/03014460.2015.1061597. View

14.

Villalobos-Comparan M, Teresa Flores-Dorantes M, Villarreal-Molina M, Rodriguez-Cruz M, Garcia-Ulloa A, Robles L . The FTO gene is associated with adulthood obesity in the Mexican population. Obesity (Silver Spring). 2008; 16(10):2296-301. DOI: 10.1038/oby.2008.367. View

15.

Do R, Bailey S, Desbiens K, Belisle A, Montpetit A, Bouchard C . Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study. Diabetes. 2008; 57(4):1147-50. DOI: 10.2337/db07-1267. View

16.

Bakhashab S, Batarfi A, Filimban N, Bajouh O, Dallol A, Alqahtani M . Polycystic ovary syndrome is linked with the fat mass obesity (FTO) gene variants rs17817449 and rs1421085 in western Saudi Arabia. Bioinformation. 2022; 17(11):904-910. PMC: 9148595. DOI: 10.6026/97320630017904. View

17.

Price R, Li W, Zhao H . FTO gene SNPs associated with extreme obesity in cases, controls and extremely discordant sister pairs. BMC Med Genet. 2008; 9:4. PMC: 2254593. DOI: 10.1186/1471-2350-9-4. View

18.

Salzano F, Sans M . Interethnic admixture and the evolution of Latin American populations. Genet Mol Biol. 2014; 37(1 Suppl):151-70. PMC: 3983580. DOI: 10.1590/s1415-47572014000200003. View

19.

Mancia G, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34(28):2159-219. DOI: 10.1093/eurheartj/eht151. View

20.

Tapia-Arancibia L, Rage F, Givalois L, Arancibia S . Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol. 2004; 25(2):77-107. DOI: 10.1016/j.yfrne.2004.04.001. View